Meizer Pharma Overview
- Year Founded
-
2017
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$1.54M
- Investors
-
2
Meizer Pharma General Information
Description
Developer of target protein degradation drugs. The company is mainly engage in developing target protein degradation drug, providing users with innovative therapies and drugs.
Contact Information
Website
www.meizer.cnCorporate Office
- Room 704, Building 1, No. 58
- Yuanmei Road, Minhang District
- Shanghai
- China
Corporate Office
- Room 704, Building 1, No. 58
- Yuanmei Road, Minhang District
- Shanghai
- China
Meizer Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 19-Jan-2021 | $1.54M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 13-Mar-2019 | Completed | Generating Revenue |
Meizer Pharma Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Highthink Med | VC-Backed Company | Minority | ||
| Furen Medicine R and D | Corporation | Minority |
Meizer Pharma FAQs
-
When was Meizer Pharma founded?
Meizer Pharma was founded in 2017.
-
Where is Meizer Pharma headquartered?
Meizer Pharma is headquartered in Shanghai, China.
-
What industry is Meizer Pharma in?
Meizer Pharma’s primary industry is Drug Discovery.
-
Is Meizer Pharma a private or public company?
Meizer Pharma is a Private company.
-
What is Meizer Pharma’s current revenue?
The current revenue for Meizer Pharma is .
-
How much funding has Meizer Pharma raised over time?
Meizer Pharma has raised $1.54M.
-
Who are Meizer Pharma’s investors?
Highthink Med and Furen Medicine R and D have invested in Meizer Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process